Our top pick for
24/5 trading
Thermo Fisher Scientific Inc (TMO) is a leading diagnostics & research business with stocks listed in the US. It closed the previous market day at US$555.52. During the previous open market day, the price has varied from a low of USD541.67 to a high of USD562.32. Thermo Fisher Scientific is listed on the NYSE. All prices are listed in US Dollars.
Our top pick for
24/5 trading
Our top pick for
Copy trading
Our top pick for
Mobile app
Thermo Fisher Scientific's shares were split on a 3:2 basis on 5 June 1996. So if you had owned 2 shares the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.
52-week range | US$492.9336 - US$627.0151 |
---|---|
50-day moving average | US$531.865 |
200-day moving average | US$570.7466 |
Target price | US$646.5283 |
PE ratio | 34.1221 |
Dividend yield | US$1.52 (0.29%) |
Earnings per share (TTM) | US$15.97 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $555.52
1 week (2025-01-06) | 3.41% |
---|---|
1 month (2024-12-13) | 5.43% |
3 months (2024-10-14) | -7.99% |
6 months (2024-07-12) | 1.36% |
1 year (2024-01-12) | 2.06% |
---|---|
2 years (2023-01-13) | -4.85% |
3 years (2022-01-13) | -7.55% |
5 years (2020-01-13) | 67.32% |
We currently don't have a partnership for that product, but we have other similar offers to choose from (how we picked these ):
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Thermo Fisher Scientific shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0953. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$10.6 billion (£8.4 billion).
The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure stock profitability.
Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as US$492.9336 up to US$627.0151. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.792. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).
Revenue TTM | US$42.4 billion |
---|---|
Operating margin TTM | 18.06% |
Gross profit TTM | US$19 billion |
Return on assets TTM | 4.67% |
Return on equity TTM | 12.94% |
Profit margin | 14.48% |
Book value | 128.084 |
Market capitalisation | US$208.4 billion |
EBITDA | US$10.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 7.28% of net profits
Recently Thermo Fisher Scientific has paid out, on average, around 7.28% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.29% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $1.52 per share.
While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.
Thermo Fisher Scientific's most recent dividend payout was on 14 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 12 December 2024 (the "ex-dividend date").
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 14.69
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 12/31/2018) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 2.11/100
Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 6.69/100
Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 3.38/100
Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.
Thermo Fisher Scientific Inc was last rated for ESG on: 2019-01-01.
Total ESG score | 14.69 |
---|---|
Total ESG percentile | 14.7 |
Environmental score | 2.11 |
Environmental score percentile | 1 |
Social score | 6.69 |
Social score percentile | 1 |
Governance score | 3.38 |
Governance score percentile | 1 |
Level of controversy | 2 |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
The two easiest ways to buy Japanese stocks from Australia.
We've compared the fees and features of 40 trading platforms to find the best picks for options traders in Australia.
The best day trading platforms in Australia offer low fees and are packed full of features essential for algorithmic trading.
CHESS sponsorship allows you to directly own ASX listed shares in your own name, but it comes with some drawbacks. Find out if it's right for you.
Looking to start investing? Here are our top 6 online trading platforms for total beginners in Australia.
Here are our algorithm-selected 20 Aussie stocks worth watching in 2025.
Find out how you can invest in Nasdaq and compare a range of leading brokers that let you invest in US stocks cheaply and quickly.
Index funds are a hot topic right now, but how do you actually invest in them?
If you’re thinking of investing in gold, our guide will explain how and where to buy gold in Australia as well as the pros and cons of investing in it.
Looking to build your wealth? A guide on the investment accounts available in Australia.